www.xinhuanet.com
XINHUA online
CHINA VIEW
VIEW CHINA
 Breaking News Evo Morales wins Bolivia's presidential election    Saddam trial adjourned until Thursday    Iran, EU to continue talks over nuclear issues in January    US economy up at annual rate of 4.1% in Q3    Urgent: Foreign hostages freed in Gaza    Strong quake hits Indonesia's Sulawesi island     
Home  
China  
World  
Business  
Technology  
Opinion  
Culture/Edu  
Sports  
Entertainment  
Life/Health  
Travel  
Weather  
RSS  
  About China
  Map
  History
  Constitution
  CPC & Other Parties
  State Organs
  Local Leadership
  White Papers
  Statistics
  Major Projects
  English Websites
  BizChina
- Conferences & Exhibitions
- Investment
- Bidding
- Enterprises
- Policy update
- Technological & Economic Development Zones
Online marketplace of Manufacturers & Wholesalers
   News Photos Voice People BizChina Feature About us   
U.S. preliminarily approves generic version of AIDS medicine
www.chinaview.cn 2005-12-22 10:57:15

    WASHINGTON, Dec. 21 (Xinhuanet) -- The U.S. Food and Drug Administration (FDA) said Wednesday that it was giving tentative approval to a generic version of a pediatric AIDS drug.

    Stavudine, an antiretroviral drug manufactured by India's Aurobindo Pharma Ltd., meets FDA manufacturing, safety and efficacy standards and is considered safe for children, the agencysaid.

    But due to patent exclusivity reasons, the generic version can not be marketed in the United States. But if finally approved, it can be used by relief organizations outside the United States funded by President George Bush's AIDS relief plan.

    Stavudine for oral solution is the first generic version of the previously approved Zerit for oral solution manufactured by U.S. pharmaceutical giant Bristol-Myers Squibb. Enditem

  Related Story
Copyright ©2003 Xinhua News Agency. All rights reserved.
Reproduction in whole or in part without permission is prohibited.